This panel discussion will cover how AI could be potentially used in various aspects of REMS, including regulatory compliance, operational efficiency, as well as the ethical considerations. Additionally, the session will address the changes that have occurred in the past year and provide insights into the future developments and expectations for the upcoming year.
In this rapid-fire showcase, featuring dynamic 5-minute case studies, service providers will spotlight real-world applications, success stories, and transformative solutions that drive efficiency, compliance and elevate pharmaceutical risk management.
We are dedicated to uniting evidence and access for biopharma. Fill out the form to get in touch with our team and learn more.
Subscribe Now
Subscribe Now